Source: Eur Respir J 2004; 24 : 575-579
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Holz O., Zuhlke I., Jaksztat E., Muller K.C., Welker L., Nakashima M., Diemel K.D., Branscheid D., Magnussen H., Jorres R.A.. Lung fibroblasts from patients with emphysema show a reduced proliferation rate in culture. Eur Respir J 2004; 24 : 575-579

Member's Comments

No comment yet.

Related content which might interest you: Primary human airway epithelial cells inhibit proliferation of lung fibroblasts via transforming growth factor-β Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight Year: 2007 Cigarette smoke inhibits lung fibroblast proliferation by translational mechanisms Source: Eur Respir J 2012; 39: 705-711 Year: 2012 Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Altered phenotype of COPD primary fibroblasts from airway and alveolar tissues: proliferation and apoptosis. Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019 Fibroblast growth factor 9 (FGF9) modulates mesothelial cells plasticity to decrease differentiation and migration in vitro Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Lung fibroblasts from COPD patients presented a reduced response to TGF-β1 for proliferation and elastin synthesis Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts in vitro Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 LSC Abstract – Activation of FGF9 and 18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Differences of in vitro proliferation between skin and lung parenchymal fibroblasts in patients with emphysema Source: Eur Respir J 2006; 28: Suppl. 50, 796s Year: 2006 Telomerase activity in bleomycin-induced epithelial cell apoptosis and lung fibrosis Source: Eur Respir J 2007; 30: 205-213 Year: 2007 Apoptotic cell instillation after bleomycin attenuates lung injury through hepatocyte growth factor induction Source: Eur Respir J 2012; 40: 424-435 Year: 2012 Primary airway epithelial cell culture from lung transplant recipients Source: Eur Respir J 2005; 26: 1080-1085 Year: 2005 Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells Source: Eur Respir J 2012; 39: 446-457 Year: 2012 KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts Source: Eur Respir J 2006; 28: Suppl. 50, 340s Year: 2006 Targetingpyruvate kinase M2 isoform inhibits proliferation of human lung fibroblasts Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 The effects of hypoxia on the expression of MMP-2, MMP-9 in human lung adenocarcinoma A549 cells Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 The enhancement of Stanniocalcin-1 (STC1) secretion increases the ability of mesenchymal stem cells (MSCs) to reduce bleomycin-induced lung fibrosis in a mouse model through inhibition of endoplasmic reticulum stress (ER-stress)/TGFbeta1 pathway Source: International Congress 2014 – ILDs 1 Year: 2014 Human lung mast cells alter asthmatic airway epithelial cell function Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013